Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Barta, Stefan K.
453  Ergebnisse:
Personensuche X
?
1

Immunotherapy-resistant acute lymphoblastic leukemia cells ..:

Aminov, Sarah ; Giricz, Orsi ; Melnekoff, David T....
Journal of Clinical Investigation.  134 (2024)  8 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
2

Bendamustine lymphodepletion before axicabtagene ciloleucel..:

Ghilardi, Guido ; Paruzzo, Luca ; Svoboda, Jakub...
Blood Advances.  8 (2024)  3 - p. 653-666 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Immunologic Predictors of Vaccine Responsiveness in Patient..:

Chong, Elise A ; Kumashie, Kingsley Gideon ; Chong, Emeline R...
The Journal of Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

Efficacy and safety of bendamustine for lymphodepletion bef..:

Ghilardi, Guido ; Paruzzo, Luca ; Patel, Vrutti...
Journal of Hematology & Oncology.  17 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
5

Impact of race and social determinants of health on outcome..:

Karmali, Reem ; Machhi, Rushad ; Epperla, Narendranath...
Blood Advances.  8 (2024)  10 - p. 2592-2599 , 2024
Link: https://doi.org/10.1182/..
 
?
6

Multicenter, Real-World Study in Patients with R/R Large B-..:

Palomba, M. Lia ; Crombie, Jennifer L. ; Nastoupil, Loretta J....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S40-S41 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Targeted Therapies in the Treatment of Mantle Cell Lymphoma:

Thomas, Colin J. ; Carvajal, Veronica ; Barta, Stefan K.
Cancers.  16 (2024)  10 - p. 1937 , 2024
Link: https://doi.org/10.3390/..
 
?
8

Alternative Versus Matched Donor Allogeneic Hematopoietic T..:

Campoverde, Leticia ; Malpica, Luis ; Ramdial, Jeremy...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S243-S244 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Pralatrexate injection combined with CHOP for treatment of ..:

Iyer, Swaminathan P. ; Johnston, Patrick B. ; Barta, Stefan K.
Blood Advances.  8 (2024)  2 - p. 353-364 , 2024
Link: https://doi.org/10.1182/..
 
?
10

T cell lymphoma and secondary primary malignancy risk after..:

Ghilardi, Guido ; Fraietta, Joseph A. ; Gerson, James N....
Nature Medicine.  30 (2024)  4 - p. 984-989 , 2024
Link: https://doi.org/10.1038/..
 
?
11

Bendamustine as Lymphodepletion for Brexucabtagene Autoleuc..:

Chong, Elise A. ; Chong, Emeline R. ; Therwhanger, Dylan...
Transplantation and Cellular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
12

Subsequent malignant neoplasms in patients previously treat..:

Melody, Megan ; Epperla, Narendranath ; Shouse, Geoffrey...
Blood Advances.  8 (2024)  10 - p. 2327-2331 , 2024
Link: https://doi.org/10.1182/..
 
?
13

Real-World Treatment Patterns and Clinical Outcomes With Br..:

Barta, Stefan K. ; Liu, Nicholas ; DerSarkissian, Maral...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. e21-e32.e4 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Outcomes of marginal zone lymphoma treated with ibrutinib i..:

Epperla, Narendranath ; Zhao, Qiuhong ; Moyo, Tamara...
Blood Advances.  8 (2024)  3 - p. 549-552 , 2024
Link: https://doi.org/10.1182/..
 
?
15

Progress and Pitfalls of Chimeric Antigen Receptor T Cell I..:

Angelos, Mathew G. ; Patel, Ruchi P. ; Ruella, Marco.
Transplantation and Cellular Therapy.  30 (2024)  2 - p. 171-186 , 2024
Link: https://doi.org/10.1016/..
 
1-15